Novartis $9.7 billion acquisition of The Medicines Company

Overview:

• Swiss pharmaceuticals company Novartis has completed its $9.7 billion acquisition of New Jersey-based The Medicines Company. 
• To finance the acquisition, Novartis entered into a $7 billion short term credit agreement and completed a $5 billion multi-tranche bond offering. 
• Novartis was advised by Bank of America, while the financial advisers for The Medicines Company were Goldman Sachs and JP Morgan Securities.

Natasha Forrest - Researcher